Comparison of the antihypertensive efficacy and adverse reactions to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: substudies of the Medical Research Council's trials of treatment of mild hypertension: Medical Research Council Working Party

Journal of Clinical Pharmacology


As substudies of the Medical Research Council's trials of treatment of mild hypertension and of hypertension in the elderly, two studies were carried out comparing the effects of different doses of two diuretics on blood pressure, concentrations of some biochemical variables, and the incidence of subjective adverse reactions. In one study, in which 484 patients with mild hypertension participated, daily doses of bendrofluazide 5 mg and 10 mg, with and without oral potassium supplements, were compared. In the second, involving 701 elderly patients with hypertension, daily doses of hydrochlorothiazide 25 mg together with amiloride 2.5 mg were compared with hydrochlorothiazide 50 mg together with amiloride 5 mg. The mean (+/- SD) durations of treatment were 35 +/- 17 months in the first study and 10 +/- 7 months in the second. Neither study showed any significant difference in blood pressure response to the two doses of diuretic, whereas biochemical changes and the reported incidence of subjective adverse reactions were dose-related. In the first study, potassium supplementation with potassium chloride 16.8 or 33.6 mmol did not have a significant effect on the fall in serum potassium level, which was only slightly reduced, and did...Continue Reading


Nov 1, 1977·Clinical Pharmacology and Therapeutics·M G TweeddaleJ Ruedy
Aug 1, 1978·Clinical Pharmacology and Therapeutics·B J MatersonJ Morledge
May 31, 1978·European Journal of Clinical Pharmacology·B Beermann, M Groschinsky-grind
Oct 30, 1976·The Medical Journal of Australia·S CarneyT Morgan
Mar 21, 1985·The New England Journal of Medicine·N M KaplanM Simmons
Mar 21, 1985·The New England Journal of Medicine·J P Kassirer, J T Harrington
Feb 14, 1970·Lancet·B M Wright, C F Dore
May 1, 1973·Acta Medica Scandinavica·B DegnbolT Marner
Jul 1, 1984·The American Journal of Medicine·N M Kaplan
Jan 1, 1981·European Journal of Clinical Pharmacology·J G RussellI S Humphries
Apr 1, 1980·Clinical Pharmacology and Therapeutics·L E RamsayJ J Morton
Nov 9, 1963·Lancet·W I CRANSTONL M MUTCH

❮ Previous
Next ❯


Jan 1, 1989·Journal of Steroid Biochemistry·M de GasparoJ Ménard
Nov 1, 1993·Clinical and Experimental Hypertension : CHE·C I Johnston
Jan 1, 1994·Current Medical Research and Opinion·J M StarrL Hadley
Oct 5, 2002·American Journal of Physical Anthropology·M Victoria MonsalveDana V Devine
Apr 19, 2018·The Cochrane Database of Systematic Reviews·James M WrightRupam Gill
Aug 17, 2017·The Cochrane Database of Systematic Reviews·Vijaya M MusiniJames M Wright
Jul 10, 2009·The Cochrane Database of Systematic Reviews·James M Wright, Vijaya M Musini
Oct 13, 2018·British Journal of Clinical Pharmacology·Tatiana V MacfarlaneThomas M MacDonald
Apr 14, 1990·BMJ : British Medical Journal·J E CarlsenP Johansen
Jul 21, 2006·The Cochrane Database of Systematic Reviews·H O DickinsonJ Mason
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Diana DiaoFrancois Gueyffier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.